Intercepting Cancer Communiques: Exosomes as Heralds of Malignancy.
In clinical oncology, detecting and treating disease as early as possible is the brass ring to be grasped. Does a new test based on circulating exosomes bring it closer for patients with pancreas cancer?
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA 98195, USA. Electronic address: srh@fhcrc.org.
Sunil R
SR
Hingorani
D000818:Animals; D014408:Biomarkers, Tumor / Q000097:blood / Q000378:metabolism*; D055354:Exosomes / Q000235:genetics / Q000378:metabolism*; D005434:Flow Cytometry; D053673:Glypicans / Q000097:blood / Q000378:metabolism*; D006801:Humans; D051379:Mice; D009154:Mutation; D010190:Pancreatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D018631:ras Proteins / Q000235:genetics / Q000378:metabolism
D014408:Biomarkers, Tumor; D053673:Glypicans; D018631:ras Proteins